JPMorgan upgrades Teradyne stock rating on long-term growth drivers By Investing.com

JPMorgan upgraded Teradyne to Overweight and lifted its price target to $400, citing the post-earnings pullback as creating materially higher upside against a largely unchanged revenue trajectory. The firm sees long-term growth supported by hyperscaler custom ASIC demand, HBM-related memory TAM expansion, and CPO/SiPh testing, and expects 40% earnings growth in both fiscal 2027 and fiscal 2028 after 80% growth in fiscal 2026. Despite the bullish call, the stock remains volatile after a 20% post-earnings drop and still trades at 70.59x earnings, with Northland remaining cautious at $270.

Analysis

The key second-order effect is not the upgrade itself, but the signal that the AI test ecosystem is still in an early monetization phase: if merchant GPU testing and advanced interconnect testing are only now becoming material, then the real earnings leverage sits with whichever vendors can capture incremental sockets without major capex inflation. That favors the incumbent with the broadest installed base, but it also creates a window for smaller ATE suppliers, probe card vendors, and semiconductor equipment names to see a sympathy rerating if hyperscaler/custom silicon capex stays intact into 2027-2028.

The market’s reaction should be bifurcated by horizon. Over the next few weeks, this is a valuation reset story: a high-multiple stock that just reset on guidance will remain vulnerable to any sign of air pockets in order timing, especially if investors use the rally to fade the move. Over 12-24 months, though, the more important risk is that the “AI test TAM” narrative becomes crowded and then self-defeating if customers extract pricing concessions or dual-source more aggressively as volumes scale.

The contrarian read is that the pullback may still be too shallow if the Street is extrapolating near-term AI spend too linearly. A large part of the bullish thesis depends on 2027-2028 mix expansion, not just unit growth, which means any delay in next-gen GPU or optical networking ramps can compress the implied growth bridge quickly. In other words: the stock can deserve a higher multiple only if management proves that the new TAMs are not just additive in theory but accretive in realized gross margin and throughput utilization.

Key Decisions for Investors

• Go long TER on a 2-4 week horizon only on a retest of the post-earnings low; use a tight stop 8-10% below support, because the setup is still headline-sensitive and prone to air pockets.
• Express the structural view as a pair: long TER / short a basket of lower-quality semi-capex proxies with weaker AI exposure, to isolate relative upside from advanced test content expansion while dampening market beta.
• Buy 6-12 month call spreads on TER rather than outright equity if you want upside to the 35x-40x multiple regime; the convexity is attractive if 2027-2028 estimate revisions continue, but implied valuation risk is still high.
• Watch for confirmation in the next 1-2 quarters from bookings and utilization in advanced compute test; if those metrics decelerate, cut the long and rotate into the beneficiaries of capex reallocation rather than staying anchored to the name.
• Use any further squeeze higher to trim into strength above the broker target zone; the stock’s path likely becomes more range-bound once the initial “upgrade after drawdown” flow is exhausted.